{"id":"W2921353678","doi":"10.1136/ejhpharm-2019-eahpconf.269","title":"4CPS-120 Erlotinib in non-small-cell lung cancer without epidermal growth factor receptor activating mutations","year":2019,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Internal medicine; Epidermal growth factor receptor; Oncology; Lung cancer; Chemotherapy; Taxane; Erlotinib Hydrochloride; Adverse effect; Cancer; Breast cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000600258,0.0001400378,0.0003975919,0.0002906953,0.0002097907,0.0003455224,0.0001742729,0.0003074211,0.00279577],"category_scores_gemma":[0.000570191,0.00008599959,0.0005306053,0.00054119,0.0002058662,0.0001969205,0.0002223133,0.0002719072,0.0006055702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004158853,"about_ca_system_score_gemma":0.0007093833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001463682,"about_ca_topic_score_gemma":0.00258827,"domain_scores_codex":[0.9997061,0.00009995438,0.00005111016,0.00003160316,0.00005661098,0.00005462244],"domain_scores_gemma":[0.9995041,0.0001035569,0.0001944514,0.00003635941,0.00004793751,0.0001136245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03553092,0.001911113,0.8036793,0.00117611,0.0004111246,0.002677371,0.0001775479,0.0006703644,0.01453353,0.0001937378,0.004801393,0.1342374],"study_design_scores_gemma":[0.003591359,0.02551783,0.9409249,0.0002294084,0.0004180968,0.008193136,0.0002004928,0.001246626,0.006795536,0.0001900535,0.01267367,0.00001894508],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952377,0.002169886,0.0001194485,0.0000920381,0.00001905217,0.00009861082,0.000940706,0.00001530896,0.001307239],"genre_scores_gemma":[0.9974081,0.0007673842,0.0001565427,0.0001116447,0.00002933831,0.00005881088,0.001063317,0.000004246616,0.000400543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00279577,"threshold_uncertainty_score":0.009352744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03810566551067331,"score_gpt":0.4265117572884367,"score_spread":0.3884060917777634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}